| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-115-5-337 |
| P698 | PubMed publication ID | 1863022 |
| P2093 | author name string | P. P. Rosen | |
| M. L. Lesser | |||
| P. Rhodes | |||
| R. T. Senie | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | menstrual cycle | Q83864 |
| internal medicine | Q11180 | ||
| P304 | page(s) | 337-342 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Timing of Breast Cancer Excision during the Menstrual Cycle Influences Duration of Disease-free Survival | |
| P478 | volume | 115 |
| Q34100841 | An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survival |
| Q54471327 | Association between timing of surgery during menstrual cycle and prognosis in pre-menopausal breast cancer. |
| Q33747939 | Biologic rhythms in the immune system |
| Q36116472 | Body weight and vascular invasion in post-menopausal women with breast cancer |
| Q44226572 | Breast cancer and the menstrual cycle |
| Q61900272 | Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women |
| Q34285969 | Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know? |
| Q36116259 | Characteristics of the menstrual cycle at the time of surgery for breast cancer |
| Q43748478 | Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients. |
| Q40684734 | Current management of carcinoma of the breast |
| Q54504887 | Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome. |
| Q35128737 | Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update |
| Q72681312 | Effect of menstrual phase on surgical treatment of breast cancer |
| Q71789801 | Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients |
| Q50538085 | Effects of sex steroids on proliferation in normal mammary tissue. |
| Q41163163 | Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer |
| Q62497094 | Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases |
| Q41513707 | Gender differences in host defense mechanisms |
| Q36228114 | Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8(th) Annual Women's Cancer Initiative - Tata Memorial Hospital (WCI-TMH) Conference |
| Q72799309 | Hyperplasia and breast cancer |
| Q41085418 | Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats |
| Q36136368 | Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells |
| Q42369318 | Industry is not the dark side, but an essential partner to make progress in reproductive health |
| Q73409046 | Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer |
| Q43716770 | Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia |
| Q38523644 | Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases |
| Q40751734 | Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome? |
| Q33561220 | Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study |
| Q73793905 | Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI |
| Q73033937 | Menstrual phase and breast cancer surgery: influence on clinical outcome or pitfall of statistical analysis? |
| Q41749490 | Menstrual timing of breast cancer surgery |
| Q33262921 | Modeling biological rhythms in failure time data |
| Q40644017 | Molecular mechanisms of antiestrogen action in breast cancer |
| Q36713318 | Perioperative endocrine status and prognosis in early breast cancer |
| Q36277982 | Progesterone regulates the proliferation of breast cancer cells - in vitro evidence |
| Q36079936 | Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy |
| Q36135369 | Serum progesterone and prognosis in operable breast cancer |
| Q33707212 | Special considerations in breast cancer risk and survival |
| Q68319070 | Surgical procedures, menstrual cycle phase, and prognosis in operable breast cancer |
| Q46561374 | Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones. |
| Q36525832 | The Relationship between Surgery and Phase of the Menstrual Cycle Affects Survival in Breast Cancer |
| Q35978381 | The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma |
| Q36679506 | The timing of breast cancer surgery within the menstrual cycle |
| Q36618820 | Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer |
| Q98386330 | Timing of breast cancer surgery during the menstrual cycle-is there an optimal time of the month? |
| Q36608823 | Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study |
| Q37157588 | Timing of breast cancer surgery in relation to the menstrual cycle--the rise and fall of a hypothesis |
| Q24234561 | Timing of breast surgery in premenopausal breast cancer patients |
| Q73819928 | Timing of surgery during the menstrual cycle and prognosis of breast cancer |
| Q33538451 | Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis |
| Q44893090 | Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer |
| Q33779172 | Timing of surgery with regard to the menstrual cycle in women with primary breast cancer |
| Q36621686 | Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications |
| Q36115058 | Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? |
Search more.